Skip to main content
SpringerLink
Log in
Book cover

Advances in Cardiomyopathies pp 245–253Cite as

The Role of β-Blockers in the Management of Heart Failure: Results of Controlled Trials

  • Conference paper

  • 79 Accesses

Abstract

Congestive heart failure is a common clinical syndrome, the incidence of which apperars to be increasing. Over recent years there have been considerable advances in the understanding of both the pathophysiology and management of heart failure. However, despite these advances, morbidity and mortality remain high and heart failure is still a major public health problem. In New Zealand there are about 8000 admissions of about 5000 patients each year with heart failure, or the equivalent of 330 hospital beds being occcupied all year, every year by patients with heart failure [1]. Management of heart failure accounts for about 1.5% to 2% of total health budgets in Western countries [1,2].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Doughty R, Yee T, Sharpe N, MacMahon S (1995) Hospital admissions and deaths due to congestive heart failure in New Zealand 1988-91. NZ Med J 108:473–475

    CAS  Google Scholar 

  2. McMurray J, Hart W, Rhodes G (1993) An evaluation of the cost of heart failure to the National Health Service in the UK. Br J Med Econ 6:99–110

    Google Scholar 

  3. The CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316:1429–1435

    Google Scholar 

  4. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 325:293–302

    Article  Google Scholar 

  5. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, Di Bianco R, Zeldis SM, et al for the PROMISE Study Research Group (1991) Effect of oral milrinone on mortality in severe heart failure. N Engl J Med 325:1468–1475

    Article  PubMed  CAS  Google Scholar 

  6. Doughty RN, MacMahon S, Sharpe N (1994) ²-blockers in heart failure: promising or proved? J Am Coll Cardiol 23:814–821

    Article  PubMed  CAS  Google Scholar 

  7. Packer M (1992) The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20:248–254.

    Article  PubMed  CAS  Google Scholar 

  8. Szakacs JE, Cannon A (1958) Norepinephrine myocarditis. Am J Clin Pathol 30:425–435

    PubMed  CAS  Google Scholar 

  9. Bigger JT. (1987) Why patients with congestive heart failure die: arrhythmias and sudden cardiac death. Circulation 75 [Suppl IV] IV28–IV35

    PubMed  Google Scholar 

  10. Mancia G (1990) Sympathetic activation in congestive heart failure. Eur Heart J 11 [Suppl A]:3–11

    Article  PubMed  Google Scholar 

  11. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I (1975) Effect of chronic β-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 37:1022–1036

    Article  PubMed  CAS  Google Scholar 

  12. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I (1980) Beneficial effects of longterm β-blockade in congestive cardiomyopathy. Br Heart J 44:117–133

    Article  PubMed  CAS  Google Scholar 

  13. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I (1979) Prolongation of survival in congestive cardiomyopathy by β-receptor blockade. Lancet 1:1374–1376

    Article  PubMed  CAS  Google Scholar 

  14. Ikram H, Fitzpatrick D (1981) Double-blind trial of chronic oral β-blockade in congestive cardiomyopathy. Lancet 2:490–492

    Article  PubMed  CAS  Google Scholar 

  15. Currie PJ, Kelly MJ, McKenzie A, Harper RN, Lim YL, Federman J et al (1984) Oral β-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy. J Am Coll Cardiol 3:203–209

    Article  PubMed  CAS  Google Scholar 

  16. Anderson JL, Lutz JR, Gilbert EM, Sorensen SG, Yanowitz FG, Menlove RL et al (1985) A randomised trial of low-dose β-blockade therapy for idiopathic dilated cardiomyopathy. Am J Cardiol 55:471–475

    Article  PubMed  CAS  Google Scholar 

  17. Engelmeier RS, O’Connell JB, Walsh R, Rand N, Scanlon PJ, Gunnar RM (1985) Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomised, placebo-controlled trial. Circulation 72:536–546

    Article  PubMed  CAS  Google Scholar 

  18. Sano H, Kawabata N, Yonezawa K, Hirayama H, Sakuma I, Yasuda H (1989) Metoprolol was more effective than captopril for dilated cardiomyopathy in Japanese patients Circulation 80 [Suppl II]:II–118 (abstr)

    Google Scholar 

  19. Leung WH, Lau CP, Wong CK, Chen CH, Tai YT, Lim SP (1990) Improvement in exercise performance and haemodynamics by labetalol in patients with idiopathic dilated cardiomyopathy. Am Heart J 119:884–890

    Article  PubMed  CAS  Google Scholar 

  20. Pollock SG, Lystash J, Tedesco C, Craddock G, Smucker ML (1990) Usefulness of bucindolol in congestive heart failure. Am J Cardiol 66:603–607

    Article  PubMed  CAS  Google Scholar 

  21. Gilbert EM, Anderson JL, Deitchman D, Yanowitz FG, O’Connell JB, Renlund DG et al. (1990) Long-term β-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Am J Med 88:223–229

    Article  PubMed  CAS  Google Scholar 

  22. Woodley SL, Gilbert EM, Anderson JL, O’Connell JB, Deitchman D, Yanowitz FG, et al. (1991) β-blocker with bucindolol in heart failure caused by ischaemic versus idiopathic dilated cardiomyopathy. Circulation 84:2426–2441

    Article  PubMed  CAS  Google Scholar 

  23. Paolisso G, Gambardella, Marrazzo G, Varza M, Teasuro P, Varricchio M, et al. (1992) Metabolic and cardiovascular benefits deriving from β-adrenergic blockade in chronic congestive heart failure. Am Heart J 123:103–110

    Article  PubMed  CAS  Google Scholar 

  24. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA et al. for the Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group (1993) Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342:1441–1446

    Article  PubMed  CAS  Google Scholar 

  25. Wisenbaugh T, Katz I, Davis J, Essop R, Skulargis J, Middlemost S et al. (1993) Longterm (3 month) effects of a new β-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy. J Am Coll Cardiol 21:1094–1100

    Article  PubMed  CAS  Google Scholar 

  26. Fisher ML, Gottlieb SS Plotnick GD, Greenberg NL, Patten RD, Bennett SK, et al. (1994) Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomised trial. J Am Coll Cardiol 23:943–950

    Article  PubMed  CAS  Google Scholar 

  27. Bristow MR, O’Connell JB, Gilbert EM, French WJ, Leatherman G, Kantrowitz NE, et al. for the Bucindolol Investigators (1994) Dose-response of chronic β-blocker treatment in heart failure from either idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Circulation 89:1632–1642

    Article  PubMed  CAS  Google Scholar 

  28. Eichorn EJ, Heesch CM, Barnett JH, Alvarez LG, Fass SM, Grayburn PA et al. (1994) Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomised, double-blind, placebo-controlled study. J Am Coll Cardiol 24:1314–1320

    Article  Google Scholar 

  29. Metra M, Nardi M, Giubbini R, Dei Cas L. (1994) Effects of short-and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 24:1678–1687

    Article  PubMed  CAS  Google Scholar 

  30. CIBIS Investigators and Committees (1994) A Randomized Trial of β-Blockade in Heart Failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90:1765–1773.

    Google Scholar 

  31. Olsen SL, Gilbert EM, Renlund DG, Taylor EO, Yanowitz FD, Bristow MR (1995) Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomised study. J Am Coll Cardiol 25:1225–1231

    Article  PubMed  CAS  Google Scholar 

  32. Krum H, Sackner-Bernstein JD, Goldsmith RL, et al. (1995) Double-blind, placebo controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 92:1499–1506

    Article  PubMed  CAS  Google Scholar 

  33. Australia New Zealand Heart Failure Research Collaborative Group (1997) Effects of carvedilol in patients with congestive heart failure due to ischemic heart disease: final results from the Australia New Zealand Heart Failure Research Collaborative Group trial. Lancet 349:375–380

    Article  Google Scholar 

  34. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Shusterman NH, for the US Carvedilol Heart Failure Study Group (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349–1355.

    Article  PubMed  CAS  Google Scholar 

  35. Australia New Zealand Heart Failure Research Collaborative Group (1995) Effects of carvedilol, a vasodilator β-blocker in patients with congestive heart failure due to ischemic heart disease. Circulation 92:212–218

    Article  Google Scholar 

  36. Sweeney ME, Fletcher BJ, Fletcher GF (1989) Exercise testing and training with β-adrenergic blockade: role of drug washout period in “unmasking ” a training effect. Am Heart J 118:941–948

    Article  PubMed  CAS  Google Scholar 

  37. Lipkin DP, Scriven AJ, Crake T (1986) Six minute walk test for assessing exercise capacity in chronic heart failure. Br Med J 92:653–655

    Article  Google Scholar 

  38. Franciosa JA, Park M, Levine TB (1981) Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 47:33–39

    Article  PubMed  CAS  Google Scholar 

  39. Clark A, Coats A (1994) Mechanisms of exercise intolerance in cardiac failure: abnormalities of skeletal muscle and pulmonary function. Curr Opin Cardiol 9:305–314

    Article  PubMed  CAS  Google Scholar 

  40. Drexler H (1995) Changes in the peripheral circulation in heart failure. Curr Opin Cardiol 10:268–273

    Article  PubMed  CAS  Google Scholar 

  41. Doughty RN, Whalley GA, Gamble G, MacManon S, Sharpe N on behalf of Australia New Zealand Heart Failure Research Collaborative Group (1997) Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol 29:1060–1066

    Article  PubMed  CAS  Google Scholar 

  42. Cohn JN, Fowler MB, Bristow MR, Colucci WS, Gilbert EM, Kinal V et al. for the Carvedilol Study Group (1996) Effect of carvedilol in severe chronic heart failure J Am Coll Cardiol 27 [Suppl A]: 169A (abstr)

    Google Scholar 

  43. Bristow MR, Gilbert EM, Abraham W, Adams KF, Fowler MB, Hershberger RE et al. for the MOCHA Investigators (1996) Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 94:2807–2816

    Article  PubMed  CAS  Google Scholar 

  44. Packer M, Colucci WS, Sackner-Bernstein O, Liang CS, Goldscher DA, Freeman I et al. for the PRECISE Study Group (1996) Double-blind placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Circulation 94:2793–2799

    CAS  Google Scholar 

  45. Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB et al. (1996) Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation 94:2800–2806

    Article  PubMed  CAS  Google Scholar 

  46. Cleland JGF, Swedberg K (1996) Carvedilol for heart failure, with care. Lancet 347:1199–1200

    Article  PubMed  CAS  Google Scholar 

  47. Pfeffer MA, Stevenson LW (1996) β-adrenergic blockers and survival in heart failure. N Engl J Med 334:1396–1397

    Article  PubMed  CAS  Google Scholar 

  48. Doughty RN, Rodgers A, Sharpe N, MacManon S (1997) Effects of β-blocker therapy on mortality in patients with heart failure. A systematic overview of randomised controlled trials. Eur Heart J 18:560–565

    CAS  Google Scholar 

Download references

Authors
  1. R. Dougthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Sharpe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Cardiology, Ospedale Maggiore, Trieste, Italy

    Fulvio Camerini

  2. Division of Cardiology, IRCCS Policlinico S. Matteo, Pavia, Italy

    Antonello Gavazzi

  3. Institute of Clinical Phisiology, CNR, Ospedale Niguarda, Milan, Italy

    Renata De Maria

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Italia

About this paper

Cite this paper

Dougthy, R., Sharpe, N. (1998). The Role of β-Blockers in the Management of Heart Failure: Results of Controlled Trials. In: Camerini, F., Gavazzi, A., De Maria, R. (eds) Advances in Cardiomyopathies. Springer, Milano. https://doi.org/10.1007/978-88-470-2155-6_29

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2155-6_29

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2181-5

  • Online ISBN: 978-88-470-2155-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation